Mount Yale Investment Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$298K Sell
3,805
-4,286
-53% -$335K 0.02% 459
2025
Q1
$586K Sell
8,091
-472
-6% -$34.2K 0.05% 297
2024
Q4
$634K Buy
8,563
+162
+2% +$12K 0.05% 303
2024
Q3
$554K Buy
8,401
+2,441
+41% +$161K 0.05% 326
2024
Q2
$551K Sell
5,960
-609
-9% -$56.3K 0.04% 324
2024
Q1
$628K Sell
6,569
-1,651
-20% -$158K 0.05% 311
2023
Q4
$627K Buy
8,220
+1,740
+27% +$133K 0.06% 279
2023
Q3
$449K Sell
6,480
-101
-2% -$7K 0.05% 319
2023
Q2
$621K Sell
6,581
-1,693
-20% -$160K 0.07% 278
2023
Q1
$685K Buy
8,274
+1,573
+23% +$130K 0.08% 254
2022
Q4
$500K Sell
6,701
-3,031
-31% -$226K 0.06% 277
2022
Q3
$804K Sell
9,732
-103
-1% -$8.51K 0.11% 200
2022
Q2
$935K Buy
9,835
+3,034
+45% +$288K 0.12% 178
2022
Q1
$801K Sell
6,801
-447
-6% -$52.6K 0.09% 231
2021
Q4
$939K Sell
7,248
-2,572
-26% -$333K 0.1% 213
2021
Q3
$1.11M Sell
9,820
-976
-9% -$111K 0.13% 179
2021
Q2
$1.12M Sell
10,796
-201
-2% -$20.8K 0.14% 161
2021
Q1
$920K Sell
10,997
-4,019
-27% -$336K 0.12% 179
2020
Q4
$1.37M Buy
15,016
+85
+0.6% +$7.76K 0.19% 119
2020
Q3
$1.19M Sell
14,931
-1,097
-7% -$87.6K 0.17% 131
2020
Q2
$1.11M Sell
16,028
-1,042
-6% -$72K 0.2% 117
2020
Q1
$1.07M Sell
17,070
-1,554
-8% -$97.7K 0.24% 105
2019
Q4
$1.37M Buy
18,624
+33
+0.2% +$2.42K 0.24% 102
2019
Q3
$1.48M Sell
18,591
-1,389
-7% -$111K 0.27% 92
2019
Q2
$1.42M Sell
19,980
-3,159
-14% -$224K 0.26% 89
2019
Q1
$1.48M Buy
23,139
+393
+2% +$25.1K 0.28% 90
2018
Q4
$1.31M Sell
22,746
-3,291
-13% -$190K 0.27% 91
2018
Q3
$1.37M Buy
26,037
+369
+1% +$19.4K 0.24% 93
2018
Q2
$1.25M Sell
25,668
-2,628
-9% -$127K 0.24% 99
2018
Q1
$1.32M Buy
+28,296
New +$1.32M 0.28% 89